The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya. by Gitonga, Caroline W et al.
Gikandi, PW; Noor, AM; Gitonga, CW; Ajanga, AA; Snow, RW
(2008) Access and barriers to measures targeted to prevent malaria in
pregnancy in rural Kenya. Tropical medicine & international health
, 13 (2). pp. 208-17. ISSN 1360-2276
Downloaded from: http://researchonline.lshtm.ac.uk/2182/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Access and barriers to measures targeted to prevent malaria in
pregnancy in rural Kenya*
Priscilla W. Gikandi1, Abdisalan M. Noor1, Carol W. Gitonga1, Antony A. Ajanga1 and Robert W. Snow1,2
1 Malaria Public Health and Epidemiology Group, Centre for Geographic Medicine Research-Coast, Kenya Medical Research
Institute ⁄Wellcome Trust Research Programme, Nairobi, Kenya
2 Centre for Tropical Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
Summary objectives To evaluate barriers preventing pregnant women from using insecticide-treated nets (ITN)
and intermittent presumptive treatment (IPT) with sulphadoxine-pyrimethamine (SP) 5 years after the
launch of the national malaria strategy promoting these measures in Kenya.
methods All women aged 15–49 years were interviewed during a community survey in four districts
between December 2006 and January 2007. Women pregnant in the last 12 months were asked about
their age, parity, education, use of nets, ITN, antenatal care (ANC) services and sulphadoxine-pyri-
methamine (SP) (overall and for IPT) during pregnancy. Homestead assets were recorded and used to
develop a wealth index. Travel time to ANC clinics was computed using a geographic information
system algorithm. Predictors of net and IPT use were defined using multivariate logistic regression.
results Overall 68% of pregnant women used a net; 52% used an ITN; 84% attended an ANC clinic
at least once and 74% at least twice. Fifty-three percent of women took at least one dose of IPT-SP,
however only 22% took two or more doses. Women from the least poor homesteads (OR = 2.53, 1.36–
4.68) and those who used IPT services (OR = 1.73, 1.24–2.42) were more likely to sleep under any net.
Women who used IPT were more likely to use ITNs (OR = 1.35, 1.03–1.77), while those who lived
more than an hour from an ANC clinic were less likely (OR = 0.61, 0.46–0.81) to use ITN. Women with
formal education (1.47, 1.01–2.17) and those who used ITN (OR: 1.68, 1.20–2.36) were more likely to
have received at least one dose of IPT-SP.
conclusion Although the use of ITN had increased 10-fold and the use of IPT fourfold since last
measured in 2001, coverage remains low. Provider practices in the delivery of protective measures
against malaria must change, supported by community awareness campaigns on the importance of
mothers’ use of IPT.
keywords malaria, pregnancy, antenatal care, intermittent presumptive treatment, sulphadoxine-
pyrimethamine, insecticide-treated nets, Kenya
Introduction
Infection with Plasmodium falciparum during pregnancy
often results in maternal anaemia and low birth weight,
under stable endemic transmission (Brabin 1983; Steketee
et al. 1996, 2001; Parise et al. 1998; Shulman et al. 1999).
Malaria contributed to an estimated 400 000 cases of
anaemia among pregnant African women in 1995 (Guyatt
& Snow 2001a) and indirectly caused about 100 000
infant deaths through low birth weight (Guyatt & Snow
2001b). Two relatively simple interventions during preg-
nancy to reduce the incidence of malaria attributable-
anaemia and low birth weight: intermittent presumptive
treatment (IPT) using sulphadoxine-pyrimethamine (SP) in
the second and third trimesters and the use of insecticide-
treated nets (ITN) (Gamble et al. 2006; Garner & Gu¨lm-
ezoglu 2006). WHO recommends these two interventions
to combat the consequences of malaria in pregnancy by the
WHO in the Africa Region (WHO 2004).
In 2000 the Roll Back Malaria (RBM) movement set a
target of providing at least 60% of pregnant women with
an ITN and at least two courses of IPT by the year 2010
(WHO 2000). Given the relatively high, but variable,
uptake of antenatal care (ANC) clinics by pregnant women
in Africa (http://www.measuredhs.com), this Abuja target
should be attainable by 2010. However there are important
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differentials in ANC utilization related to parity, age,
education and access (Mlay et al. 1994; Chandrashekar
et al. 1998; Sinhababu et al. 2006). Understanding the
level of coverage of IPT and ITN among women at highest
risk of the consequences of malaria on morbidity and
pregnancy outcomes is critical to interpretation of overall
estimates of RBM coverage targets.
We present the findings of a recent survey of pregnant
women and their use of IPT and ITN in four rural districts
of Kenya in 2006, 5 years after the launch of the national
malaria strategy and we highlight the current barriers to
effective coverage among biologically and economically
vulnerable women.
Methods
The Kenyan malaria in pregnancy strategy
Much of the scientific evidence generated to support the
policy position on the use of IPT and ITN during
pregnancy in Africa was developed in Kenya (Parise et al.
1998; Shulman et al. 1999; Van Eijk et al. 2002, 2004a,b;
Njagi et al. 2003; Ter Kuile et al. 2003). In April 2001
the Kenyan National Malaria Strategy was launched with
the management and prevention of malaria in pregnancy
as a major component with a stated aim to ensure that
60% of pregnant women were using an ITN or effective
IPT by 2006 (MOH 2001). The Division of Reproductive
Health (DRH) of the Kenyan Ministry of Health (MOH)
developed an implementation strategy to ensure effective
clinical management of anaemia and delivery of IPT
among ANC attendees with the support of the John
Hopkins Program for International Education in Repro-
ductive Health (JHPIEGO) and financial support from the
UK’s Department for International Development (DFID).
The programme began in July 2000 in the two districts of
Kilifi and Busia, as a pilot project and was expanded to
four districts (Kwale, Taita-Taveta, Homa Bay and
Bondo) in 2002. The fundamentals of the Focussed
Antenatal Care programme included the provision of
cascade in-service training through decentralized training
centres that aimed to reach all cadres of nursing and
clinical staff involved in seeing ANC clients. For malaria
these in-service training initiatives were supported with
laminated visual aids covering the basics of diagnosis and
management of anaemia and the timing and dosing of
presumptive SP provision during the second and third
trimesters of pregnancy. Within the framework of the
national malaria strategy, IPT is provided at no charge in
public health services.
The provision of ITN to pregnant women formed part
of a separate implementation strategy managed by the
Division of Malaria Control (DOMC) and other service
delivery partners described in detail elsewhere (Noor
et al. 2007). Briefly, between 2001 and 2004 the
predominant source of ITN was the commercial retail
sector as part of a DFID-funded programme of social
marketing. In 2005 this programme changed to include
the delivery of heavily subsidized ITN through maternal
and child health and ANC clinics for children aged less
than 5 years and pregnant women. In 2006 the DOMC
launched a combined programme of ITN distribution
with the Kenya Expanded Programme for Immunisation’s
(KEPI) catch-up mass measles vaccination initiative,
providing free ITN to children in 21 districts and free
distribution in a further 24 districts not linked to
vaccination.
Study sites and population
The study was conducted in four districts purposively
sampled in collaboration with the MOH to provide
detailed longitudinal data on changing access to inter-
ventions between 2001 and 2006. The study districts
represent the range of malaria epidemiological situations
that prevail across Kenya: Kwale on the coast with
seasonal, high intensity malaria transmission; Bondo on
the shores of Lake Victoria with high intensity perennial
transmission, Greater Kisii district (combining the new
districts of Kisii Central and Gucha) with low, seasonal
transmission conditions of the Western highlands, and
Makueni district, a semi-arid area with acutely seasonal,
low malaria transmission. The use of ANC services,
including measures to prevent malaria during pregnancy,
at the launch of the KNMS were described by Guyatt
et al. (2004). Across the four districts in 2001, 11% of
rural women pregnant in the last 12 months had slept
under a net during the pregnancy and only 4.6% had
slept under an ITN, 23% had taken any treatment
course of SP during the pregnancy and less than 5.1% of
women had had two presumptive treatment courses of
SP in their second and third trimesters (Guyatt et al.
2004).
Of the 230 rural and urban national census enumeration
area (EA) communities sampled during 2001, 72 rural EAs
were re-sampled in 2003 to form the basis of a more
detailed homestead longitudinal surveillance. Following
community sensitization, all homesteads within an EA
were mapped using GPS (Garmin etrex; Garmin Ltd,
Kansas, USA). We explained the purpose of the longitudi-
nal study to heads of homesteads and asked them to
participate. In November 2003 all consenting homesteads
were recruited into the homestead cohort, de jure resident
homestead members enumerated including details of date
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of birth and sex and each homestead member issued a
unique identifier linked to their district, EA and household
location. Annual censuses were undertaken between
December and January 2004 ⁄2005 2005 ⁄2006 and
2006 ⁄2007.
All women aged 15–49 years at the time of the
2006 ⁄2007 census were selected from the previous annual
census to participate in a detailed interview on their
pregnancy histories. Women who provided individual
consent for interview and those agreeing to participate
were questioned on their birth histories and highest levels
of formal education attained. For women reporting a
pregnancy that had resulted in a delivery in the last
12 months or who reported being currently pregnant
further questions were asked on their use of named ANC
services, SP (overall or when they were not sick), net use
and whether these were treated in last 6 months or were
long-lasting treated nets during the last or current preg-
nancy.
Defining wealth quintiles
Details were recorded on each homestead related to key
asset indicators including: homestead head education level
and occupation, housing characteristics (type of wall, roof
and floor), source of drinking water, type of sanitation
facility, homestead size and persons per sleeping room.
Principal components were used to construct a wealth
index (Filmer & Pritchett 2001). Wealth asset indices were
developed separately for each district to allow for innate
differences in the meaning of different assets between
districts. Each homestead was then classified into a district-
specific wealth quintile.
Defining physical access to ANC clinics
Transport routes and topography; government mission
and private health services; and physical barriers to
travel (hills, rivers and protected areas) were mapped
within each district and assembled in arcgis 9.0 (ESRI
Inc., USA) (Noor et al. 2003). Because most people in
the study districts walk to health facilities (Noor et al.
2006), walking times were computed using data from the
digitized footpaths and roads between the nearest ANC
provider and woman’s homestead. A travel time algo-
rithm developed in C++ code was used to define speed
differentials along the various footpath and road surfaces
(Noor et al. 2006). Barriers such as rivers, forests and
parks were masked as impassable. Where a path
traversed a river or other water features, however, travel
speed remained unchanged from that of the intersecting
road.
Data entry and analysis
Data entry and storage was undertaken using MS Access
(Microsoft, Redmond, USA), analysis was undertaken
using STATA version 9.2 (Statacorp 2003, College
Station, USA) and arcgis 9.0 (ESRI Inc., USA). A cluster-
adjusted chi-squared test was performed to construct
precision estimates around proportions and compare them
across districts. Regression analyses were undertaken on
combined data to examine factors that explained the use
of nets; ITN; any IPT and two doses of IPT by pregnant
women. Univariate regression analyses were first per-
formed to identify which of the predictor variables were
significant to the four outcome measures. In the univariate
analyses any predictor with a P-value < 0.15 was con-
sidered to be a potentially important covariate of the
outcome measure. All predictors meeting the entrance
criteria were used to estimate a multivariable logistic
regression model to identify their combined effect on a
given outcome measure. The multivariate models were
fitted using the STATA xtgee command with an
exchangeable working correlation matrix. This procedure
uses generalized estimating equations (GEE) to account
for the potential correlation of observations on pregnant
women seen in the same EA while accounting for the
variability between clusters. All results were weighted for
unequal probability of selection of EA within each district
(weight = 1 ⁄probability of selecting an EA). Both the
cluster-adjusted chi-squared test and the multivariate
regression were adjusted for the effect of the variation
between districts. Odds ratio (OR), 95% confidence
interval (CI) and P-values were recorded for each
predictor.
Results
A total of 4720 eligible women aged 15–49 years were
selected for interview, 42 (0.9%) refused participation, 106
(2.2%) normally resident women were visiting at the time
of the survey and during subsequent follow-up visits within
2 weeks. Of the 4549 women interviewed, 976 (21.5%)
had been pregnant within the last 12 months, including
216 who were pregnant at the time of survey. Overall 81%
of pregnant women attended an ANC clinic at least once.
ANC usage remained similar and high across all districts
with 59% of women averaging at least three visits
(Table 1). ANC attendances were higher (92.6% at least
once; 85.0% at least twice) when those currently pregnant
women, a proportion of whom would be in early
pregnancy and would not have began visiting an ANC
clinic or using IPT, were excluded from the analysis
(Table 1).
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Net and treated net use during pregnancy
Overall 68% of women used a net during their pregnancy
with Makueni reporting the lowest coverage (60.6%).
Approximately half of the pregnant women (51.6%) used
nets treated with insecticide, with small differences
between districts and when currently pregnant women
were excluded from the analysis (Table 1). Therefore,
subsequent results in this section are presented with all
women who were pregnant within the last 12 months as
the denominator. The routine net distribution through
ANC clinics was the main source of nets (53%) followed
by the retail commercial sector (22%) while 16% of
women slept under nets obtained from a free mass
distribution that took place in two phases in July and
September (Noor et al. 2007) that targeted children under
the age of 5 years. The remaining proportion of nets (9%)
was obtained through other small-scale distributions (data
not shown).
ITN and net use did not vary significantly with the age
of the pregnant woman (Table 2). However, when only
adolescent mothers (15–19 years of age), who are con-
sidered to be a special risk group were selected (n = 59),
net ⁄ ITN use was lower (net use: 56%; ITN use: 44%)
than the overall proportion for all other age categories
(net use: 69%; ITN use 66%) (data not shown). Although
net and ITN use was higher among multigravid women
compared to secundigravid and primigravid women this
was not statistically significant (net use: Cluster-adjusted
P = 0.2555; ITN use: Cluster-adjusted P = 0.2416)
Table 2 Percentage* (cluster adjusted) any net use, ITN and SP use by age, parity, education, wealth and travel times to the ANC clinics in
the 72 communities combined across the four districts (% (n), [95% CI])
Net use ITN use
Presumptive
SP 1 + at ANC
Presumptive
SP 2 + at ANC
Age*
15–29 years 68.3 (449) [63.3–73.3] 52.7 (347) [47.9–57.6] 54.1 (327) [49.5–58.6] 23.4 (140) [18.9–25.7]
30–49 years 66.3 (219) [58.9–73.7] 49.4(162) [41.6–57.2] 51.0 (156) [44.1–57.7] 19.2 (57) [12.6–25.7]
Parity
Primigravid 61.9 (95) [53.7–70.1] 46.5 (69) [37.9–55.1] 53.5 (80) [44.9–62.1] 30.3 (45) [20.8–39.7]
Secundigravid 66.0 (128) [57.1–74.9] 49.3 (96) [39.6–59.0] 58.0 (98) [52.3–63.8] 25.3 (44) [17.4–33.2]
Multigravid 69.9 (445) [64.5–75.2] 53.9 (344) [48.8–59.1] 51.2 (305) [46.4–56.0] 18.4 (108)  [14.0–23.0]
Education
No formal education 59.3 (127) [52.0–66.7] 45.0 (100) [36.4–53.6] 41.7 (89) [34.0–49.4] 18.9 (35) [11.7–26.2]
Primary or higher
education
69.0 (541)  [64.4–73.7] 52.7 (409)  [48.3–57.1] 54.9 (394)  [50.5–59.4] 22.5 (162) [17.9–27.1]
Wealth quintile
Women residing in
most poor homesteads
62.3 (166) [56.2–68.5] 48.9 (129) [42.1–55.8] 47.4 (116) [41.0–53.9] 19.2 (47) [11.8–26.5]
Women residing in very
poor homesteads
67.9 (154) [60.1–75.7] 51.7 (118) [42.3–61.0] 46.8 (106) [38.9–54.7] 15.7 (32) [10.3–21.2]
Women residing in poor
homesteads
63.2 (136) [53.9–72.5] 44.9 (97) [37.4–52.6] 54.1 (102) [44.8–63.5] 26.0 (50) [19.0–33.0]
Women residing in less
poor homesteads
71.9 (117) [62.7–81.2] 57.8 (93) [47.9–67.8] 63.4 (96) [53.2–73.7] 28.8 (45) [20.4–37.1]
Women residing in least
poor homesteads
82.8 (94)§ [74.3–91.2] 61.4 (72) [49.5–73.3] 62.7 (63)  [49.9–75.5] 24.7 (23) [15.7–33.8]
Travel times
Within 1 h of an
ANC clinic
72.8 (338)  [68.0–77.5] 58.2 (254) § [52.5–63.9] 51.2 (265) [45.6–56.7] 20.3 (109) [14.2–26.3]
More than 1 h of an
ANC clinic
63.2 (330) [56.5–69.8] 45.9 (265) [40.5–51.3] 54.7 (218) [48.4–61.0] 23.5 (88) [18.2–28.8]
*Age groups were selected pragmatically for sample size reasons rather than targeting special risk groups such as adolescents (15–19 years,
n = 59).
Note: P-value for comparison of proportions between multiple categories of variables: P < 0.05; P < 0.01; §P < 0.001. A cluster
adjusted chi-squared test was used to examine the significance of differences in proportions yielding wider confidence intervals and
conservative P-values compared to the unadjusted chi-squared test. The differences in proportions had a similar pattern when analysis was
undertaken excluding women who were currently pregnant (data not shown).
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(Table 2). A significantly higher proportion of women
with primary or higher level of education used nets (69%)
than women without formal education (59%)
(P = 0.017). 53% of women with some formal education
used ITN compared to 49% of women without
(P = 0.082). The largest disparities in net use were in
relation to wealth status (Table 2). Eight-three percent of
pregnant women from the least poor homesteads used
nets compared to 62% of pregnant women from the
poorest homesteads (P < 0.001). Similarly, 61% women
in the least poor homesteads reported using an ITN
compared 49% of those in the poorest homesteads
(P = 0.082). Distance to ANC clinics, however, influenced
both net use (P = 0.018) and ITN use (P = 0.001), with
fewer women reporting use if they lived more than 1 h
walking distance to an ANC clinic compared to those
within an hour (Table 2).
IPT use during pregnancy
Fifty-nine percent of women reported taking at least one
dose of SP from any source during their pregnancy, 53%
took at least one dose of SP as IPT and 22% took the
recommended two doses or more at an ANC clinic
(Table 1). Usage of at least two doses of presumptive IPT
at ANC clinics varied between districts (Table 1). When
currently pregnant women were excluded from the
analysis, 65% of women took at least one dose of SP
from any source during pregnancy, 58% took at least one
dose as IPT and 24% took the recommended two doses
or more (Table 1). Because IPT usage did not vary
significantly when the currently pregnant women were
excluded from the analysis, subsequent analysis of IPT
usage relies on all women who were pregnant within the
last 12 months.
There were no significant differences in the propor-
tional use of at least one dose of SP as presumptive IPT
from ANC clinics with respect to age, parity or travel
time to an ANC clinic (Table 2). Among adolescent
mothers (15–19 years), however, IPT usage was lower
than that of older women with only 39% and 20% using
at least one and two doses of IPT during pregnancy (data
not shown). There were also differences with respect to
mothers’ education and wealth status: women with no
formal education (42%) and those from most poor
homesteads (47.4%) were less likely to have used any IPT
compared to those with at least primary education (55%)
or from the least poor homesteads (62.7%) (P = 0.007,
and 0.046, respectively). The characteristics of women
who had at least two doses of IPT from ANC clinics
followed a similar pattern to those who received at least
one dose of SP with the exception that more primigravid
women (30%) reported accessing at least two doses of SP
compared to multigravid women (18%) (P = 0.012)
(Table 2).
Multivariate analysis: predictors of net; ITN; and IPT use
among pregnant women
When the analysis in Table 2 excluded women who were
currently pregnant, the relationship between the explan-
atory variables and the outcomes (net use; ITN use; and
IPT use) remained the same as when all women were
included (data not shown). The multivariate analysis was
therefore undertaken using data on all women who were
pregnant within the last 12 months. Mother’s education
and age were not statistically associated with the use of
nets or ITN when examined in combination with the
other predictors. However, the use of nets was signifi-
cantly associated with (a) the reported use of IPT from
an ANC clinic (OR = 1.73; CI = 1.24–2.42); (b) those
who were multigravid (OR = 1.53; CI = 1.01–2.35);
(c) those who were from the least poor homesteads
(OR = 2.53; CI = 1.36–2.09); and (d) those who were
within 1 h walking distance to an ANC clinic
(OR = 0.67; CI = 0.48–0.93) (Table 3). Use of ITN,
however, was significantly associated only with reported
use of at least one dose of IPT from an ANC clinic
(OR = 1.35; CI = 1.03–1.77) and distance to the ANC
clinic used by pregnant women (OR = 0.61; CI = 0.46–
0.81).
For both single and multiple doses of IPT from ANC
clinics the multiple regression failed to identify any
significant influence on use associated with mothers age,
gravidity, wealth status or distance to the nearest ANC
clinic (Table 3). However, mothers with primary or
higher level of education (OR = 1.47; CI = 1.02–2.17)
and those who used a net (OR = 1.68; CI = 1.20–2.34)
were more likely to use at least a single dose of IPT from
ANC but this was not observed for two or more doses
(Table 3).
Discussion
There have been substantial increases in the use of ITN
and at least two doses of presumptive IPT with SP by
pregnant women between 2001 (ITN 5% and IPT 5%,
Guyatt et al. 2004) and 2006 (ITN 52% and IPT 22%,
Table 1). These increases can only be attributed to the
expansion of national funding and service provision
around ITN and IPT delivery. In Bondo district there has
been a long-term distribution of nets in Asembo Bay
division by the United States Centre for Disease Control
and Prevention (CDC) (Philips-Howard et al. 2003) as
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part of community-based studies in the district. How-
ever, only two clusters were sampled from this division
in which only 17 ⁄213 women were seen, of whom 82%
used a net and this may partly explain the proportion-
ately higher ITN use in Bondo. More than half of the
nets used by pregnant women in all districts were
obtained from ANC clinics with an additional 16%
being nets that were targeted at children under the age of
5 years through free mass distribution (Noor et al.
2007). Information on whether this mother’s shared the
nets with children under the age of 5 years was not
recorded.
Table 3 Multivariate analysis results of predictors* of net use, ITN use, IPT1 use and IPT2 use among pregnant women in rural Kenya.
Data from the four districts were combined for this analysis. OR and 95% CI were adjusted for the effect of districts
Use of nets by pregnant
women
Use of ITN by pregnant
women
Use of IPT1 by pregnant
women
Use of IPT2 by pregnant
women
OR
(95% CI) P-Value
OR
(95% CI) P-Value
OR
(95% CI) P-Value
OR
(95% CI) P-Value
Age category
15–29 years Ref.
30–49 years 0.75
(0.490–1.145)
0.182
Mother’s education
No Ref. Ref. Ref.
Yes 1.26
(0.86–1.84)
0.230 1.25
(0.85–1.83)
0.250 1.47
(1.01–2.17)
0.049
Parity
Primigravid Ref. Ref.
Secundigravid 1.13
(0.70–1.80)
0.623 1.06
(0.62–1.81)
0.834
Multigravid 1.53
(1.01–2.35)
0.050 1.42
(0.93–2.15)
0.103
Use of IPT
No Ref. Ref. NA – NA –
Yes 1.73
(1.24–2.42)
0.001 1.35
(1.03–1.77)
0.032
Use of Nets
No NA – NA –
Yes 1.68
(1.20–2.36)
0.003
Socio-economic status
Most poor Ref. Ref. Ref. Ref.
Very poor 1.29
(0.88–1.90)
0.192 1.12
(0.73–1.71)
0.602 0.93
(0.61–1.40)
0.718 0.69
(0.42–1.16)
0.162
Poor 0.96
(0.60–1.55)
0.864 0.81
(0.52–1.26)
0.349 1.28
(0.81–2.01)
0.290 1.41
(0.81–2.46)
0.222
Less poor 1.48
(0.94–2.35)
0.094 1.39
(0.88–2.22)
0.169 1.80
(1.08–2.99)
0.024 1.48
(0.89–2.47)
0.133
Least poor 2.53
(1.36–4.68)
0.003 1.54
(0.84–2.84)
0.165 1.57
(0.88–2.83)
0.130 1.20
(0.65–2.20)
0.558
Distance to ANC clinics
Within 1 h Ref. Ref.
Greater than 1 h 0.67
(0.48–0.93)
0.017 0.61
(0.46–0.81)
0.001
*Predictors whose multivariate results are listed in this table had P < 0.15 in the univariate analyses for a given outcome measure.
Ref. = reference level. NA =Not applicable: applies when an explanatory variable on a row is the same as the outcome measure on the
column indicating that a variable cannot be applied as an outcome measure and as it is own explanatory variable in a regression. Values in
bold denote results remained similar when currently pregnant women were excluded from the analysis
(data not shown).
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A 10- or fourfold increases in coverage over the past
5 years might appear to be great successes, however,
both ITN and IPT coverage estimates remain below
international and national targets, particularly for IPT.
More than 73% of women attended an ANC clinic at
least twice during their pregnancy and SP has been
widely available at all clinics in these districts between
2005 and 2006 (Zurovac et al. 2006). This suggests that
there are several barriers to effective implementation of
IPT and we would argue that these are probably factors
related to access to services; socio-economic status and
factors not reported here but operating at the provider or
facility level. We did not examine provider awareness or
perceptions about the provision of SP to pregnant
women as IPT and therefore cannot comment directly on
this. Interestingly, of all pregnant women who used nets,
53.4% had obtained them through routine services at
clinics targeting pregnant women and children under the
age of 5 years (data not shown). Of these, 58% had at
least one dose of IPT-SP; only 24% had two or more
doses. This suggests three probable reasons for low IPT
uptake: health workers at clinics that provide IPT
services do not give appropriate advice such that many
women do not return for follow-up doses; or where
appropriate advice is provided, many women do not
return for follow-up IPT doses due to personal, geo-
graphic and ⁄or socio-economic factors; or many clinics,
including those that distribute nets, do not provide IPT
services at all.
Indirectly, SP as an effective treatment for malaria was
increasingly less well accepted from both observed clinical
efficacy (EANMAT 2003) and observed prescriptions at
clinics well before the introduction of the new drug policy
involving artemether-lumefantrine to clinics during the
third quarter of 2006 (Amin et al. 2007). Despite
declining clinical efficacy of SP this drug might still offer
some protection against placental infections and the
adverse consequences of malaria during pregnancy in
Kenyan women (Van Eijk et al. 2007). At least three
doses of SP might be a better strategy for IPT during
pregnancy where HIV prevalence is high (Parise et al.
1998). In our study only 6% of women accessed at least
three doses (Table 1). The continued use of SP as IPT for
pregnant women is a difficult message to convey to
providers of ANC services who are now told not to
prescribe SP for clinical malaria. Removing SP from
treatment kits for public health facilities over the next
12 months will create a vacuum with respect to IPT for
pregnant women at the clinic level. Further studies into
the impact of the removal of SP from the treatment kit,
IPT provider practices at ANC clinics and the level of
awareness and perception of mothers with regards to
ITN ⁄ IPT usage are required to confirm the results of this
study for informed decision-making.
In Kenya, despite the low IPT coverage, high ANC
usage has consistently been reported and in the study
districts usage is over 80% for at least one visit to ANC
clinic and 74% for at least two visits during pregnancy
(Table 2). Therefore, we would suggest that changing
provider practices at ANC clinics in the delivery of IPT
services, supported by community awareness campaigns
to educate mothers on the importance of IPT usage, is
required. Any new IPT strategies will have to consider the
increasing malaria parasite resistance to SP and explore
other candidate therapies, probably as combination reg-
imens. Several such candidates are in phase II ⁄ III clinical
trials, some with good prospects for the near future
(Vallely et al. 2007).
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